Quantcast

Latest Amphetamines Stories

2011-04-28 04:00:00

PHILADELPHIA, April 28, 2011 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced positive results from a signal-finding study of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules (CII) assessing its effect in a prospective examination of adults with negative symptom predominant schizophrenia. This study met its pre-defined primary end points. Vyvanse is a prescription medicine currently approved in the US, Canada,...

2011-04-25 07:33:00

NORTH LIBERTY, Iowa, April 25, 2011 /PRNewswire/ -- KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder (ADHD), will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106. KP106 is a new chemical entity (NCE) comprised of d-amphetamine, and was identified utilizing KemPharm's proprietary...

2011-04-25 07:33:00

WARREN, N.J., April 25, 2011 /PRNewswire/ -- MonoSol Rx, LLC ("MonoSol Rx"), the developer of PharmFilm® drug delivery technology, today announced that the Company has entered into a development and commercialization partnership with KemPharm, a biopharmaceutical company focused on the discovery and development of new, safer therapies for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), pain, and cardiovascular disease. Under terms of the agreement, the...

d6ca1e4d3b6da20512a281f31d5447011
2011-04-07 10:35:00

Dutch researchers have found that long term use of the drug ecstasy can cause structural brain damage, according to a report published in the Journal of Neurology, Neurosurgery and Psychiatry. The hippocampus is the area of the brain responsible for long term memory and was the focus of this study. MRI scans were used to measure the volume of the hippocampus in two groups of young men. Ten of them were in their mid-20s who were long term ecstasy users, while the other group consisted of seven...

2011-04-06 01:00:00

DUBLIN and PHILADELPHIA, April 6, 2011 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that its subsidiary Shire LLC has filed a lawsuit in the U.S. District Court for the Southern District of New York against Watson Pharmaceuticals, Inc. and its subsidiaries Watson Laboratories, Inc.-Florida, Watson Pharma, Inc., Andrx Corporation, and Andrx Pharmaceuticals, L.L.C. for infringement of Shire's U.S. Reissue Patent No....

ed2dab6972c2a932f98549dc770692c51
2011-03-30 06:20:00

Australian researchers studying the effects of drug use in the real world, attended parties where people were using a particular drug known as ecstasy (which often also contains a variety of other drugs), discovering that the drug posed far greater risk on users' brains than anyone previously believed. Dr. Thomas Newton, a professor at Baylor College of Medicine, who was not involved in the study, told Reuters that what was most concerning "is that most studies looking at toxicity in people...

2011-03-11 00:00:28

Teens and young adults are coming up with creative ways to use legal substances to achieve a high. The Recovery Place finds major concern in the negative health issues and addiction still inherent to these new "legal" drugs. Fort Lauderdale, FL (PRWEB) March 10, 2011 Teens and young adults are coming up with creative ways to use legal substances to achieve a high. The Recovery Place finds major concern in the negative health issues and addiction still inherent to these new "legal" drugs....

2011-02-24 10:14:00

DUBLIN, Ireland and PHILADELPHIA, February 24, 2011 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that its subsidiaries Shire LLC and Shire Development Inc. (collectively "Shire") have received a new Paragraph IV Notice Letter from Watson Laboratories, Inc. in Fort Lauderdale, Florida ("Watson") advising of the filing of an Abbreviated New Drug Application ("ANDA") for a generic version of all approved strengths...

2011-02-23 08:22:43

(Ivanhoe Newswire) -- The use of amphetamines such as benzedrine and dexerdrine, commonly used to treat ADHD, depression, and narcolepsy, appear to cause an increased risk of developing Parkinson's disease, according to this study. The study involved 66,348 people in northern California who had participated in the Multiphasic Health Checkup Cohort Exam between 1964 and 1973 and were evaluated again in 1995. The average age of the participants at the start of the study was 36 years old. Of the...

2011-02-21 13:38:21

New research shows people who have used amphetamines such as benzedrine and dexedrine appear to be at an increased risk of developing Parkinson's disease, according to a study released today that will be presented at the American Academy of Neurology's 63rd Annual Meeting in Honolulu April 9 to April 16, 2011. Benzedrine and Dexedrine are amphetamines often prescribed to increase wakefulness and focus for people with attention deficit hyperactivity disorder and narcolepsy, a disorder that can...


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related